Article Impact Level: HIGH Data Quality: STRONG Summary of Nature Materials, 1–13. https://doi.org/10.1038/s41563-025-02234-6 Avery Rui Sun et al.
Points
- Researchers developed a hybrid biomaterial to independently study how the stiffness of the extracellular matrix and its biochemical composition contribute to the functional decline associated with cardiac aging.
- The study found that aged heart fibroblasts cultured on a scaffold with young biochemical signals began to exhibit rejuvenated characteristics, even when the material was mechanically stiff.
- Conversely, young cardiac cells placed onto a matrix with aged biochemical cues started to display premature signs of dysfunction, highlighting the powerful influence of the chemical environment.
- These results strongly suggest that the biochemical environment surrounding heart cells is more influential than mechanical stiffness in driving the cellular-level processes associated with heart aging.
- This discovery opens a new therapeutic direction for preserving heart health by focusing on restoring the youthful biochemical composition of the extracellular matrix rather than the cells themselves.
Summary
A recent study published in Nature Materials investigates the distinct roles of extracellular matrix (ECM) stiffness and biochemical composition in cardiac aging. To decouple these two intertwined factors, investigators developed a novel hybrid biomaterial named DECIPHER. This platform combines decellularized ECM from young or aged murine hearts with a synthetic hydrogel, enabling the independent tuning of mechanical stiffness while preserving the native biochemical ligand presentation. This model was designed to isolate the specific contributions of matrix stiffness versus biochemical cues to age-related cellular dysfunction, a challenge that has historically complicated research in the field.
Using this system, primary murine cardiac fibroblasts were cultured on scaffolds representing different combinations of age-related biochemical cues and stiffness levels. The results demonstrated that the biochemical environment was a more potent regulator of fibroblast phenotype than mechanical stiffness. Specifically, aged cardiac fibroblasts seeded on scaffolds with a “young” ECM ligand profile exhibited a rejuvenated phenotype, including a significant shift in the expression of thousands of genes related to aging and function, even when the matrix was mechanically stiff. Conversely, young fibroblasts cultured on an “aged” ECM showed premature signs of dysfunction and senescence, regardless of whether the scaffold was soft or stiff.
These findings suggest that the biochemical signals of a young ECM can override the profibrotic effects of a mechanically stiff environment, promoting fibroblast quiescence and potentially reversing age-related cellular changes. The study concludes that targeting the biochemical composition of the cardiac ECM presents a promising therapeutic strategy for mitigating age-related cardiovascular dysfunction and promoting cardiac rejuvenation. This approach shifts the therapeutic focus from the heart cells themselves to their surrounding microenvironment, offering a new direction for future clinical interventions.
Link to the article: https://www.nature.com/articles/s41563-025-02234-6
References Sun, A. R., Ramli, M. F. H., Shen, X., Kannivadi Ramakanth, K., Chen, D., Hu, Y., Vidyasekar, P., Foo, R. S., Long, Y., Zhu, J., Ackers-Johnson, M., & Young, J. L. (2025). Hybrid hydrogel–extracellular matrix scaffolds identify biochemical and mechanical signatures of cardiac ageing. Nature Materials, 1–13. https://doi.org/10.1038/s41563-025-02234-6
